The Enhanced Games
Prompt:
I want a rigorous, evidence-based analysis of the recent Enhanced Games (2026), where athletes were permitted to compete using substances approved by the U.S. Food and Drug Administration but banned by traditional sporting bodies.
First, conduct an extensive online search covering:
What actually happened at the 2026 Enhanced Games (results, standout performances, records, field quality, and whether any records were broken or recognized).
The broader context and reception (media coverage, expert commentary, and athlete participation levels).
The current scientific evidence on the effects of performance-enhancing drugs (PEDs) on athletic performance.
Do not rely on general knowledge alone—ground your response in up-to-date, verifiable sources.
Core Questions to Address
1. Are performance-enhancing drugs “non-transformative”?
Evaluate the claim that PEDs do not function as a “super-serum” that can elevate average athletes to elite status, but instead provide marginal gains that matter primarily at the highest levels of competition.
What does the empirical literature say about the magnitude and consistency of PED effects (e.g., anabolic steroids, EPO, stimulants)?
Are these effects typically marginal, or can they be large and outcome-determining?
How do PEDs interact with training, recovery, and long-term performance development?
2. Retrospective evaluation of doped athletes
Assess the following argument:
Athletes who broke records while using PEDs were likely already close to those records in a clean state, and therefore should be evaluated more leniently in terms of their underlying ability.
Is this inference justified given the available evidence?
What do we know (and not know) about counterfactual clean performance?
How do cumulative training effects and long-term PED use complicate this assessment?
3. Nonlinear and heterogeneous effects of PEDs
Investigate the possibility that PED effects are not uniform across athletes.
Is there evidence that certain individuals experience disproportionate or nonlinear gains from PEDs due to genetic or physiological differences?
Are there known responder vs. non-responder dynamics (e.g., in muscle hypertrophy, oxygen capacity, recovery)?
Could this create a selection effect where the most successful dopers are those who benefit unusually strongly from PEDs?
4. Interpreting the Enhanced Games results
Using the actual outcomes of the 2026 event:
Do the results support or undermine the idea that PEDs provide only marginal advantages?
How should we interpret cases where enhanced athletes underperformed expectations, or where clean athletes outperformed them?
What alternative explanations (field quality, preparation, timing, incentives) need to be considered?
Requirements for the Response
Base your analysis on current, high-quality sources and clearly distinguish evidence from speculation.
Where evidence is limited or uncertain, state this explicitly.
Avoid oversimplification—engage with competing interpretations and uncertainties.
Prioritize depth over brevity.
The goal is not just to critique my claims, but to situate them within the best available empirical and theoretical understanding of performance-enhancing drugs and elite athletic performance.
Responses: GPT 5.5 Thinking, Claude Opus 4.6
